The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers
Antibody studies analyze immune responses to SARS-CoV-2 vaccination and infection, which is crucial for selecting vaccination strategies. In the KoCo-Impf study, conducted between 16 June and 16 December 2021, 6088 participants aged 18 and above from Munich were recruited to monitor antibodies, part...
Main Authors: | Christina Reinkemeyer, Yeganeh Khazaei, Maximilian Weigert, Marlene Hannes, Ronan Le Gleut, Michael Plank, Simon Winter, Ivan Noreña, Theresa Meier, Lisa Xu, Raquel Rubio-Acero, Simon Wiegrebe, Thu Giang Le Thi, Christiane Fuchs, Katja Radon, Ivana Paunovic, Christian Janke, Andreas Wieser, Helmut Küchenhoff, Michael Hoelscher, Noemi Castelletti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/7/1574 |
Similar Items
-
Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections
by: Christian Janke, et al.
Published: (2024-09-01) -
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
by: Ronan Le Gleut, et al.
Published: (2023-07-01) -
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
by: Katja Radon, et al.
Published: (2021-09-01) -
Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19)
by: Katja Radon, et al.
Published: (2020-06-01) -
Socioeconomic and risk-related drivers of compliance with measures to prevent SARS-CoV-2 infection: evidence from the Munich-based KoCo19 study
by: Sara Pedron, et al.
Published: (2023-05-01)